id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-0001-0010,FDA,FDA-2019-N-0001,Vaccines and Related Biological Products Advisory Committee; Notice of Meeting,Notice,Public Meetings,2020-01-06T05:00:00Z,2020,1,2020-01-06T05:00:00Z,,2020-01-06T14:52:01Z,2019-28508,0,0,090000648426ec95
FDA-2019-N-0001-0009,FDA,FDA-2019-N-0001,The Tobacco Products Scientific Advisory Committee; Notice of Meeting,Notice,Meeting,2019-12-26T05:00:00Z,2019,12,2019-12-26T05:00:00Z,,2019-12-26T14:49:56Z,2019-27774,0,0,090000648424fff4
FDA-2019-N-0001-0008,FDA,FDA-2019-N-0001,"Statement of Organization, Functions, and Delegations of Authority",Notice,General Notice,2019-12-16T05:00:00Z,2019,12,2019-12-16T05:00:00Z,,2019-12-16T18:09:47Z,2019-26952,0,0,090000648421284e
FDA-2019-N-0001-0007,FDA,FDA-2019-N-0001,Office of Minority Health and Health Equity Public Meeting on Strategies To Improve Health Equity Amidst the Opioid Crisis; Public Meeting,Notice,Meeting,2019-11-01T04:00:00Z,2019,11,2019-11-01T04:00:00Z,,2019-11-01T14:08:39Z,2019-23941,0,0,0900006484113f1d
FDA-2019-N-0001-0006,FDA,FDA-2019-N-0001,"Implementing the Food and Drug Administration’s Predictive Toxicology
Roadmap: An Update of the Food and Drug Administration’s Activities;
Public Workshop",Notice,Public Meetings,2019-08-20T04:00:00Z,2019,8,2019-08-20T04:00:00Z,,2019-08-20T13:54:52Z,2019-17876,0,0,0900006483e73ee1
FDA-2019-N-0001-0005,FDA,FDA-2019-N-0001,Food and Drug Administration Science Forum 2019; Public Workshop,Notice,Public Meetings,2019-08-19T04:00:00Z,2019,8,2019-08-19T04:00:00Z,,2019-08-19T13:03:25Z,2019-17703,0,0,0900006483e6b7db
FDA-2019-N-0001-0004,FDA,FDA-2019-N-0001,Leveraging Randomized Clinical Trials To Generate Real-World Evidence for Regulatory Purposes; Public Workshop,Notice,Public Meetings,2019-06-10T04:00:00Z,2019,6,2019-06-10T04:00:00Z,,2019-06-10T15:28:07Z,2019-12113,0,0,0900006483cfb736
FDA-2019-N-0001-0003,FDA,FDA-2019-N-0001,"Improving the Implementation of Risk-Based Monitoring Approaches of
Clinical Investigations; Public Workshop",Notice,Meeting,2019-05-31T04:00:00Z,2019,5,2019-05-31T04:00:00Z,,2019-05-31T13:20:13Z,2019-11411,0,0,0900006483cdafff
FDA-2019-N-0001-0002,FDA,FDA-2019-N-0001,"Preparation for International Cooperation on Cosmetics Regulation
Thirteenth Annual Meeting; Public Meeting",Notice,Meeting,2019-05-02T04:00:00Z,2019,5,2019-05-02T04:00:00Z,,2019-05-02T14:18:42Z,2019-08897,0,0,0900006483c29150
FDA-2019-N-0001-0001,FDA,FDA-2019-N-0001,"Advancing the Development and Implementation of Analysis Data
Standards: Key Challenges and Opportunities; Public Workshop",Notice,Meeting,2019-04-17T04:00:00Z,2019,4,2019-04-17T04:00:00Z,,2019-04-17T13:53:13Z,2019-07700,0,0,0900006483bb26ee